Edward White
Stock Analyst at HC Wainwright & Co.
(1.92)
# 3,171
Out of 5,156 analysts
338
Total ratings
32.03%
Success rate
-7.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $15.31 | +115.55% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $10.50 | +61.90% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $3.49 | +329.80% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.84 | +56.25% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $1.03 | +1,453.40% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.89 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $29.50 | +171.19% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.93 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $5.71 | +250.26% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.12 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $5.69 | +181.20% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.67 | +340.92% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.95 | +741.04% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $17.35 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.61 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.19 | +88.42% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $23.88 | +113.57% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.22 | +12.54% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $8.49 | +559.60% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.16 | +411.81% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.70 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $35.08 | -14.48% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.33 | +802.26% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $15.31
Upside: +115.55%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $10.50
Upside: +61.90%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $3.49
Upside: +329.80%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.84
Upside: +56.25%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $1.03
Upside: +1,453.40%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.89
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $29.50
Upside: +171.19%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $5.71
Upside: +250.26%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.12
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $5.69
Upside: +181.20%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.67
Upside: +340.92%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.95
Upside: +741.04%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $17.35
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.61
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $29.19
Upside: +88.42%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $23.88
Upside: +113.57%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.22
Upside: +12.54%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $8.49
Upside: +559.60%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.16
Upside: +411.81%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $35.08
Upside: -14.48%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.33
Upside: +802.26%